The Ministry of Health has registered the drug from COVID "Mirobivir"
The Ministry of HEALTH of RUSSIA has registered the drug against CORONAVIRUS "Mirobivir", follows from the data of the state register of medicines.
The main active ingredients of the drug: nirmatrelvir and ritonavir. it passed the state registration on May 4, the manufacturer is JSC Pharmasyntez. The drug will be produced in the form of tablets of 150 mg of nirmatrelvir and 100 mg of ritonavir. They will need to be taken every 12 hours, the instructions say.
The indication for the use of the drug is the treatment of mild or moderate course of covid-19 in adults. The drug should be put into civilian circulation before the beginning of next year.
Gunzburg announced the start of trials of a covid drug based on antibodies Society
In early February, the Ministry of Health registered Esperavir, a coronavirus drug based on molnupiravir, from Promomed. The drug is available in capsules of 200 and 400 mg. According to the data obtained, on the fifth day of treatment with Esperavir, more than 80% of the patients who took it showed complete death of the virus in the body, the manufacturer claims.
How the coronavirus epidemic is developing in Russia May 5 Dynamics of daily new cases of infection and deaths Created with Highcharts 8.2.2New cases of infectionDeadedEvents related to the pandemic
Jan 2020
Jan 2021
2022May02000040000600008000010000012000014000016000018000020000022000020394911.02125419.11 Sources: federal and regional headquarters for the fight against coronavirus, statements by officials Data for Russia i
See also Shoigu 02:14 Work 12 hours 6 days a week. How it is to open a business in CHINA Instructions Pro Delisting Russian companies from foreign exchanges: